Pre-operative parameters
|
Age at surgery — years
|
390
| |
192
| |
198
| | |
≤ 65
| |
174 (45 %)
| |
87 (45 %)
| |
87 (44 %)
| |
> 65
| |
216 (55 %)
| |
105 (55 %)
| |
111 (56 %)
|
0.8387
|
Patient male sex — no. (%)
|
390
|
222 (57 %)
|
192
|
103 (54 %)
|
198
|
119 (60 %)
|
0.2201
|
Diabetes — no. (%)
|
325
| |
186
| |
139
| | |
No
| |
252 (78 %)
| |
143 (77 %)
| |
109 (78 %)
| |
Yes
| |
73 (22 %)
| |
43 (23 %)
| |
30 (22 %)
|
0.7891
|
Albuminemia g/L
|
191
|
36.4 ± 7.7
|
70
|
32.6 ± 6.4
|
121
|
38.6 ± 7.4
|
<0.0001
|
Tumor Size in cm
|
301
|
3.8 ± 1.6
|
164
|
3.6 ± 1.5
|
137
|
4.0 ± 1.6
|
0.0095
|
Tumoral post-operative parameters
|
pT Local invasion — no. (%)
|
375
| |
184
| |
193
| | |
0-1-2
| |
39 (10 %)
| |
28 (15 %)
| |
11 (6 %)
| |
3–4
| |
336 (90 %)
| |
154 (85 %)
| |
182 (94 %)
|
0.0022
|
N status
|
388
| |
190
| |
198
| | |
0
| |
119 (31 %)
| |
68 (36 %)
| |
51 (26 %)
| |
1
| |
269 (69 %)
| |
122 (64 %)
| |
147 (74 %)
|
0.0365
|
Positive lymph nodes ratio
|
380
|
0.15 ± 0.19
|
182
|
0.20 ± 0.23
|
198
|
0.12 ± 0.14
|
<0.0001
|
Lymph Nodes ratio
|
< 0.2
|
380
|
279 (73 %)
| |
117 (64 %)
| |
162 (81 %)
| |
≥ 0.2
| |
104 (27 %)
| |
67 (36 %)
| |
37 (19 %)
|
<0.0001
|
Histological Grade
|
331
| |
160
| |
171
| | |
Poorly differentiated
| |
85 (26 %)
| |
23 (14 %)
| |
62 (36 %)
| |
Moderately differentiated
| |
158 (48 %)
| |
76 (48 %)
| |
82 (48 %)
| |
Well differentiated
| |
88 (26 %)
| |
61 (38 %)
| |
27 (16 %)
|
<0.0001
|
Vascular invasion
|
361
| |
186
| |
175
| | |
No
| |
242 (67 %)
| |
115 (62 %)
| |
127 (73 %)
| |
Yes
| |
119 (33 %)
| |
71 (38 %)
| |
48 (27 %)
|
0.0335
|
Lymphatic invasion
|
364
| |
189
| |
175
| | |
No
| |
230 (63 %)
| |
107 (57 %)
| |
123 (70 %)
| |
Yes
| |
134 (37 %)
| |
82 (43 %)
| |
52 (30 %)
|
0.0089
|
Perineural invasion
|
365
| |
191
| |
174
| | |
No
| |
138 (38 %)
| |
57 (30 %)
| |
81 (47 %)
| |
Yes
| |
227 (62 %)
| |
134 (70 %)
| |
93 (53 %)
|
0.0012
|
Therapeutic post-operative parameter
|
Adjuvant Chemotherapy
|
336
|
251 (75 %)
|
183
|
118 (64 %)
|
153
|
133 (87 %)
|
<0.0001
|
Lymphopenia parameters
|
Pre-operative lymphocyte counta
|
390
|
1458.9 (150–8350)
|
194
|
1492.1 (170–3052)
|
199
|
1426 (150–8350)
|
0.3362
|
Post-operative lymphocyte counta
|
299
|
1410 (200–32000)
|
127
|
1400 (251–3620)
|
172
|
1430 (200–32000)
|
0.2657
|
Follow-up parameters
|
Death events
|
393
|
309 (79 %)
|
192
|
157 (82 %)
|
198
|
152 (77 %)
|
0.2233
|
Median F-up time in months 95 % CIb
| |
66.6 (60.8–78.7)
| |
66.6 (58.0–84.0)
| |
67.2 (56.2–79.0)
| |